Proteins used for the diagnosis of lyme borreliosis

US9347943B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9347943-B2
Application numberUS-201013388178-A
CountryUS
Kind codeB2
Filing dateAug 26, 2010
Priority dateAug 28, 2009
Publication dateMay 24, 2016
Grant dateMay 24, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Chimera proteins including: (i) at least one sequence of a DbpA protein of a Borrelia species selected from B. afzelii, B. burgdorferi sensu stricto and B. garinii , and (ii) at least one sequence of an OspC protein of a Borrelia species selected from B. afzelii, B. burgdorferi sensu stricto and B. garinii . Also, a method and a kit for the in vitro diagnosis of Lyme borreliosis using said proteins.

First claim

Opening claim text (preview).

The invention claimed is: 1. A polypeptide comprising an amino acid sequence selected from the group consisting of the amino acid sequences of SEQ ID NOs: 8-14. 2. A diagnostic kit comprising the polypeptide as claimed in claim 1 . 3. The diagnostic kit as claimed in claim 2 , further comprising an anti-human-immunoglobulin labeled with a label. 4. The diagnostic kit as claimed in claim 2 , wherein the polypeptide is immobilized on a solid support. 5. The diagnostic kit as claimed in claim 2 , comprising (i) a first polypeptide comprising the amino acid sequence of SEQ ID NO: 9, (ii) a second polypeptide comprising the amino acid sequence of SEQ ID NO: 11, and (iii) a third polypeptide comprising the amino acid sequence of SEQ ID NO: 14. 6. The polypeptide as claimed in claim 1 , comprising the amino acid sequence of SEQ ID NO: 8. 7. A diagnostic kit comprising the polypeptide as claimed in claim 6 and an anti-human-immunoglobulin labeled with a label. 8. The polypeptide as claimed in claim 1 , comprising the amino acid sequence of SEQ ID NO: 9. 9. A diagnostic kit comprising the polypeptide as claimed in claim 8 and an anti-human-immunoglobulin labeled with a label. 10. The polypeptide as claimed in claim 1 , comprising the amino acid sequence of SEQ ID NO: 10. 11. A diagnostic kit comprising the polypeptide as claimed in claim 10 and an anti-human-immunoglobulin labeled with a label. 12. The polypeptide as claimed in claim 1 , comprising the amino acid sequence of SEQ ID NO: 11. 13. A diagnostic kit comprising the polypeptide as claimed in claim 12 and an anti-human-immunoglobulin labeled with a label. 14. The polypeptide as claimed in claim 1 , comprising the amino acid sequence of SEQ ID NO: 12. 15. A diagnostic kit comprising the polypeptide as claimed in claim 14 and an anti-human-immunoglobulin labeled with a label. 16. The polypeptide as claimed in claim 1 , comprising the amino acid sequence of SEQ ID NO: 13. 17. A diagnostic kit comprising the polypeptide as claimed in claim 16 and an anti-human-immunoglobulin labeled with a label. 18. The polypeptide as claimed in claim 1 , comprising the amino acid sequence of SEQ ID NO: 14. 19. A diagnostic kit comprising the polypeptide as claimed in claim 18 and an anti-human-immunoglobulin labeled with a label. 20. A method for the in vitro diagnosis of Lyme borreliosis using a biological sample, comprising: bringing the biological sample into contact with at least one polypeptide as claimed in claim 1 ; and determining whether there is formation of an immunological complex between the polypeptide and antibodies of the biological sample. 21. The method as claimed in claim 20 , wherein the antibodies of the biological sample are IgGs and/or IgMs. 22. The method as claimed in claim 21 , wherein the formation of the immunological complex is determined by adding at least one anti-human-immunoglobulin labeled with a label. 23. The method as claimed in claim 20 , wherein the polypeptide is immobilized on a solid support. 24. The method as claimed in claim 21 , wherein the polypeptide is immobilized on a solid support. 25. The method as claimed in claim 22 , wherein the polypeptide is immobilized on a solid support.

Assignees

Inventors

Classifications

  • Immunostimulants · CPC title

  • from bacteria · CPC title

  • from Spirochaetales (O), e.g. Treponema, Leptospira · CPC title

  • Detection of antibodies in sample from host which are directed against antigens from microorganisms · CPC title

  • from Spirochaetales (O), e.g. Treponema, Leptospira · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9347943B2 cover?
Chimera proteins including: (i) at least one sequence of a DbpA protein of a Borrelia species selected from B. afzelii, B. burgdorferi sensu stricto and B. garinii , and (ii) at least one sequence of an OspC protein of a Borrelia species selected from B. afzelii, B. burgdorferi sensu stricto and B. garinii . Also, a method and a kit for the in vitro diagnosis of Lyme borreliosis using…
Who is the assignee on this patent?
Levet Lionel, Mejan-Letourneur Odile, Biomerieux Sa
What technology area does this patent fall under?
Primary CPC classification G01N33/56911. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue May 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).